NewsFeeder
Headline News
- Reaction score
- 4
[$$] Biotech Firms Break U.S. IPO Drought
[at The Wall Street Journal] - Editas Medicine Inc., which is in the early stage of developing a treatment to correct disease-causing genes in patients, raised $94.4 million in its initial public offering late Tuesday.
Editas Medicine Breaks U.S. IPO Drought With First Listing of 2016 - WSJ
[at The Wall Street Journal] - Editas Medicine Inc., which is in the early stage of developing a treatment to correct disease-causing genes in patients, raised $94.4 million in its initial public offering late Tuesday.
Editas Medicine Breaks U.S. IPO Drought With First Listing of 2016 - WSJ
